Mariner’s AC Immune ACIU Stock Holding History

Mariner’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,368	Closed	-$34K	–	2827
2023 Q1	$34K	Sell	14,368 -750	-5%	-$1.74K	﹤0.01%	2689
2022 Q4	$31K	Sell	15,118 -4,869	-24%	-$12.6K	﹤0.01%	2656
2022 Q3	$63K	Buy	+19,987	New	+$63K	﹤0.01%	2282

Other funds holding ACIU

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mariner's ACIU Position: Q2 2023 in Review

Mariner sold out of AC Immune (ACIU) in Q2 2023, closing a stake of 14,368 shares — an estimated $34K sold.

Mariner first reported a position in ACIU in Q3 2022 and held it in 3 quarters. The position peaked at $63K in Q3 2022. 31 funds tracked by Wall St. Rank hold ACIU as of Q2 2023.

Mariner reported no remaining AC Immune position as of Q2 2023 after selling out during the quarter.
Mariner sold 14,368 AC Immune shares in Q2 2023, an estimated $34K.
Mariner first reported a position in AC Immune in Q3 2022 and held it in 3 quarters.
Mariner's AC Immune position peaked at $63K in Q3 2022.
31 funds tracked by Wall St. Rank held AC Immune as of Q2 2023.

Based on Mariner's 13F filing for Q2 2023, filed 11 Aug 2023.